Navigation Links
Angiotech's corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Date:6/11/2008

s or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Many such risks, uncertainties and other factors are taken into account as part of our assumptions underlying these forward-looking statements and include, among others, the following: general economic and business conditions, both nationally and in the regions in which we operate; market demand; technological changes that could impact our existing products or our ability to develop and commercialize future products; competition; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; adverse results or unexpected delays in drug discovery and clinical development processes; decisions, and the timing of decisions, made by health regulatory agencies regarding approval of our technology and products; the requirement for substantial funding to conduct research and development, to expand commercialization activities or consummate acquisitions or to service or repay debt obligations; the accuracy of our estimations of the size of the market, and the potential market, for our products in specific disease areas; sales numbers and future guidance publicly provided by Boston Scientific Corporation regarding sales of their paclitaxel-eluting coronary stent products; and any other factors that may affect performance. In addition, our business is subject to certain operating risks that may cause the actual results expressed or implied by the forward-looking statements in this report to differ materially from our actual results. These operating risks include: our ability to attract and retain qualified personnel; our ability to successfully complete preclinical and clinical development of our products; changes in business strategy or development plans; our failure to obtain patent protection for discoveries; loss of patent protection resulting from third party challenges to our pate
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... San Jose, California (PRWEB) September 30, 2014 ... generally measure the level of each type of cholesterol ... essential since the presence of excessive cholesterol levels in ... is a precursor condition to heart attack and other ... of fatality worldwide, therefore testing for cholesterol levels on ...
(Date:9/30/2014)... Basel, Switzerland (PRWEB) September 30, 2014 ... advanced software solutions for drug discovery and ... the FUNGITECT consortium has chosen Genedata Selector ... next-generation sequencing (NGS) data. FUNGITECT is a ... of invasive fungal diseases via individualized anti-fungal ...
(Date:9/30/2014)... FemCap Inc., www.femcap.com  an innovator in ... a patent No: US, 8,795,248 B2 dated Aug. 5, ... clearance in the U.S., 510(K) K121857, medical device licensure ... is related to its menstrual cup with a unique ... releasing FemmyCycle Teen, a third menstrual cup to complement ...
(Date:9/30/2014)... 2014 Lyme Research Alliance ... disease research at universities, today announced the awarding of ... identification, treatment and cure for Lyme and other tick-borne ... most applications in its history—over 20 grant proposals—a 100 ... were pleased to receive so many solid applications from ...
Breaking Biology Technology:Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3The FemmyCycle 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4
... Welcome to the event. Here extreme manufacturing meets extreme consumption. ... surplus raw materials. The remaining nations pray and hope that ... love. The trade imbalances are way out of synch; envy ... the two odd nations. , ,Somewhere out there is ...
... be encouraged by the numerous positive signs that biotech is ... few: , ,& bull; The coming of the Olympics of ... continued acquisition of Midwest biotech companies by Big Pharma ... products and technology, the flip side of this is that ...
... University of Wisconsin-Madison faculty have created a new dual-degree ... students how to apply such knowledge to problems in ... and aggression," says Clark Miller, a professor of science ... the new program. "Or what about brain mechanisms that ...
Cached Biology Technology:The world's largest factory 2The world's largest factory 3The world's largest factory 4Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4UW offers new program in neuroscience and public policy 2
(Date:9/30/2014)... Ill. (September 30, 2014) People who suffer from ... do to control their asthma besides properly taking medications ... new article in the Annals of Allergy, Asthma ... College of Allergy, Asthma and Immunology (ACAAI), asthma sufferers ... their lifestyle. The woman described in the Annals article ...
(Date:9/29/2014)... 29: Between 1970 and 2010 populations of mammals, ... dropped 52 percent, says the 2014 Living Planet ... This biodiversity loss occurs disproportionately in low-income countriesand ... countries. , In addition to the precipitous decline ... other warning signs about the overall health of ...
(Date:9/29/2014)... to support the world,s needs to make cheaper ... new and more efficient catalytic materials and processes ... several from Wayne State University, is tackling this ... from the National Science Foundation. , The nearly ... Materials for Electrocatalytic Cascade Reactions," was to Eranda ...
Breaking Biology News(10 mins):Asthma symptoms kicking up? Check your exposure to air pollution 2Half of global wildlife lost, says new WWF report 2Wayne State research aims to develop new, more efficient catalytic materials 2
... scientists are playing a major role in a NASA mission, ... layers beneath the surface of a comet. , NASA's Deep ... on 4th July, when a metre-long projectile will crash into ... crater and a plume of gas and dust. , UK ...
... to happen - you being in a car wreck or being ... greater killers win a free trip to the beach. It's really ... being in a wreck are far greater than being a shark's ... who has studied sharks for years. , Worldwide, about one million ...
... in a car wreck or being bitten by a shark? , ... trip to the beach. It's really no contest, says a Texas ... far greater than being a shark's lunch, says John McEachran, a ... years. , Worldwide, about one million people a year are killed ...
Cached Biology News:NASA probe could reveal comet life, scientists claim 2Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research 2Shark attack worries? Driving to the beach is more deadly 2
... media for spontaneous ligand immobilization can be coupled ... antigen, or receptor to create an affinity matrix ... couple ligands via primary amines. Affi-Gel 10 gel ... 6.5 to 11; Affi-Gel 15 gel couples acidic ...
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3 Monoclonal Antibody Family: Immunoglobulin Sub-Family: not assigned-Immunogl...
Chicken Anti-Human Stomatin-like 2 (STOML2 Polyclonal AntibodyNew Applications: ELISA, Western Blot...
Mouse Anti-Human Kallikrein 2 (Hk2)...
Biology Products: